← Back
$CTMX All transactions

CytomX Therapeutics, Inc.

M

$ Value

$0

Shares

37,500

Price

$0

Filed

Jun 17

Insider

Name

Ogden Christopher

Title

Chief Financial Officer

CIK

0001914523

Roles

Officer

Transaction Details

Transaction Date

2025-06-13

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

236,885

Footnotes

The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs"). | Includes 149,987 RSUs. | This transaction represents the vesting of performance stock units ("PSUs") initially granted on February 2, 2023. | The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs. | Each PSU represented a contingent right to receive one (1) share of common stock upon vesting.

Filing Info

Accession No.

0001610717-25-000236

Form Type

4

Issuer CIK

0001501989

Ogden Christopher's History

Date Ticker Type Value
2025-09-26 CTMX A $0
2025-09-26 CTMX A $0
2025-06-16 CTMX $29K
2025-06-13 CTMX $5K
2025-06-13 CTMX M $0
2025-06-13 CTMX M $0

Other Insiders at CTMX (90d)

No other insider activity at this issuer in the last 90 days.